Test Quiz: Pharmacotherapy Of Asthma

The preferred treatment for people with moderate asthma is steroids administered by MDI (Metered Dose Inhaler). Steroids help reduce inflammation in the airways, which is a key factor in asthma symptoms. MDIs are commonly used to deliver medications directly to the lungs, providing quick relief and better control of asthma symptoms. Collagen, Xanax, and Betadine are not appropriate treatments for asthma and do not address the underlying inflammation in the airways.

People with moderate asthma experience symptoms more than twice a week or have inadequate exercise tolerance. This means that they may have frequent episodes of wheezing, coughing, shortness of breath, and chest tightness. Additionally, they may struggle with physical activities and have difficulty exercising due to their asthma symptoms. These characteristics indicate a moderate level of asthma severity and may require appropriate management and treatment to control symptoms and improve overall quality of life.

Bronchodilators are a type of medication that helps relax and open up the airways in the lungs, making it easier for individuals with asthma to breathe. They are a key component of the therapeutic armamentarium for asthma because they provide immediate relief during asthma attacks and help manage symptoms in the long term. By dilating the bronchial tubes, bronchodilators improve airflow and reduce inflammation, allowing individuals with asthma to breathe more easily and effectively. Other options listed, such as oxygen masks, steam machines, and vaporub machines, are not typically considered part of the therapeutic armamentarium for asthma.

Asthma is categorized as a chronic disease because it is a long-term condition that requires ongoing management and treatment. It is not considered an endemic disease because it is not confined to a particular geographic area or population. It is also not a pandemic disease because it does not spread across multiple countries or continents. While asthma is a lifelong condition, the term "chronic" specifically refers to its persistent nature rather than its duration.

The two main important aspects of asthma are airway inflammation and hyperresponsiveness. Airway inflammation refers to the swelling and irritation of the airways, which can cause difficulty in breathing. Hyperresponsiveness refers to the exaggerated response of the airways to certain triggers, such as allergens or irritants, leading to bronchoconstriction and further narrowing of the airways. These two aspects play a crucial role in the development and symptoms of asthma.

Patients with moderate asthma should take medication daily because asthma is a chronic condition that requires daily management to control symptoms and prevent flare-ups. Regular use of medication helps to reduce inflammation in the airways, open up the air passages, and alleviate symptoms like wheezing, shortness of breath, and coughing. Taking medication daily ensures that the patient maintains optimal control over their asthma and minimizes the risk of exacerbations. It is important for patients to follow their prescribed treatment plan and consult with their healthcare provider for any adjustments or changes to their medication regimen.

Mild asthma is qualified as having short, infrequent episodes of asthma. This means that the patient experiences asthma symptoms, such as difficulty breathing, wheezing, or coughing, but these episodes occur sporadically and are not severe or prolonged. This classification suggests that the patient's asthma is relatively mild and may not require frequent or intensive treatment.

Mild asthma attacks are considered to be when a person experiences a maximum of 2 attacks per week. This means that if someone has 2 or fewer asthma attacks in a week, their condition would be categorized as mild.

Cromolyn is advantageous for asthma because it has no adverse effects. Unlike other medications that may cause side effects such as headaches or other unwanted symptoms, cromolyn is well-tolerated and does not produce any negative effects. This makes it a safer option for individuals with asthma, as they can effectively manage their condition without experiencing any additional health problems.

Cromolyn MDI is prescribed for patients with mild asthma. Cromolyn is a medication that helps to prevent asthma attacks by reducing inflammation and irritation in the airways. MDI stands for Metered Dose Inhaler, which is a device used to deliver the medication directly into the lungs. This form of treatment is commonly used for mild asthma cases as it helps to control symptoms and improve overall lung function. Betadine MDI and Betadin are not typically prescribed for asthma, and Cromolin is a misspelling of Cromolyn.